Related Experiment Videos
Changes in intermediate haemoglobins during methaemoglobin reduction by NADPH-flavin reductase.
The Biochemical Journal
|April 1, 1979
Summary
This study reveals two distinct pathways for methaemoglobin reduction by NADPH-flavin reductase, involving intermediate haemoglobin valency hybrids. Inositol hexaphosphate did not alter the reduction process.
Area of Science:
- Biochemistry
- Redox Biology
- Protein Chemistry
Background:
- Methaemoglobinemia is a condition characterized by elevated levels of methemoglobin, a form of hemoglobin that cannot effectively transport oxygen.
- NADPH-flavin reductase plays a crucial role in the reduction of methemoglobin back to functional hemoglobin.
Purpose of the Study:
- To elucidate the intermediate species and reaction pathways involved in methemoglobin reduction by NADPH-flavin reductase.
- To characterize the kinetics and mechanism of this enzymatic reduction process.
Main Methods:
- Isoelectric focusing was employed to analyze intermediate haemoglobin species.
- Kinetic analysis was performed to estimate reaction rate constants for different phases of the reduction.
Main Results:
- Two distinct valency hybrid intermediates, alpha 3+ beta 2+ and alpha 2+ beta 3+, were identified.
- The reduction proceeds through two sequential pathways, each involving these hybrid intermediates.
- Inositol hexaphosphate did not influence the overall reaction rate or pathway.
Conclusions:
- The reduction of methaemoglobin by NADPH-flavin reductase involves a complex mechanism with at least two distinct pathways.
- Understanding these pathways provides insight into hemoglobin redox chemistry and potential therapeutic strategies for methemoglobinemia.